RSS   Newsletter   Contact   Advertise with us
Post Online Media

Concordia announces leadership transition at international segment

ConcordiaConcordia International Corp., a specialty pharmaceutical company, announced that John Beighton will retire from his current role as president of the company's international segment, effective January 1, 2017.
Article continues below

READ MORE Concordia CEO Mark L. Thompson to step down

Mr. Beighton will remain with Concordia as a board member of the Company's International segment, where he will continue to be available to provide strategic advice to the International business.

Graeme Duncan, currently Managing Director for the segment, will replace Mr. Beighton as President.

Mr. Duncan joined Amdipharm Mercury Limited (now Concordia's International segment) in 2015 as Global Marketing Director and Vice President, Commercial UK and Ireland.

Mr. Duncan was promoted to Managing Director in 2016 and was responsible for the general management of the segment.

He has worked for 20 years in the life sciences sector within the areas of strategy, sales and marketing, and management.

Prior to Concordia, Mr. Duncan held senior management roles in GlaxoWellcome, GlaxoSmithKline, IVAX Pharmaceuticals and Healthcare at Home.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy